Personalized Medicine and Companion Diagnostic Market - A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment
Albany, NY (PRWEB) May 06, 2014 -- This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 263 tables & figures over 224 pages. The personalized medicine (global) market is presented as follows:
• By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode /Amgen, CELERA, MYRIAD)
• By Geography (US, UK, EU)
• By Segment (Targeted therapeutics, Companion Diagnostics, Esoteric tests, Esoteric lab services)
• By Sub-market (Companion diagnostics & therapeutic, nutrition & wellness, medical technology, pharmacogenomics, consumer genomics)
Browse Complete Report With TOC at http://www.researchmoz.us/personalized-medicine-and-companion-diagnostic-market-a-strategic-analysis-of-industry-trends-technologies-participants-and-environment-report.html.
A wealth of financial data & business strategy information is provided including:
Up-to-date company financials, sales & revenue figures
Business Model Strategies for Diagnostic, Pharmaceutical and Biotechnology Companies
Business Model Strategies for Providers. Provider Systems and Academic Medical Centres
Business Model Strategies for Payers & Governments
Private and Public Funding and Personalized Medicine Reimbursement
Revisions to Current Payment Systems and intellectual property
How to Gain Market Penetration in the EU
Cost-effectiveness and Business Value of Personalized Medicine
Consumer genomics and POC market
Therapeutics and Companion Diagnostics (e.g., BRAC Analysis, Oncotype Dx , KRAS Mutations)
Comprehensive account of company product portfolios & kits
View Other Published Reports By Kelly Scientific Publications at http://www.researchmoz.us/publisher/kelly-scientific-publications-96.html.
SWOT, Economic & Regulatory Environment specifics include:
Key strengths, weaknesses and threats influencing leading player position within the market
Technologies driving the market (e.g., New-Generation Sequencing Technologies, Ultra-High Throughput Sequencing)
Top fastest growing market segments and emerging opportunities
Top pharmaceutical companies within the IPM by market share and revenue
Comprehensive product portfolios, R&D activity and pipeline therapeutics
M&A activity and future strategies of top personalized medicine pharmacos
Personalized Medicine Regulation (UK, Germany, France, Spain, Italy)
CE-marked Personalized Medicine/Diagnostic Tests
FDA Advances in Personalized Medicine Regulation
This report highlights a number of significant Indian pharmacos and gives details of their operations, products, financials and business strategy.
23andMe
Affymetrix
Astex Pharmaceuticals
Atossa Genetics
CuraGen
Celera Corporation (Quest Diagnostics)
Celldex Therapeutics
deCode Genetics (Amgen)
Illumina
Genelex
Myriad
Nodality
Qiagen
Browse Reports in Medical Equipments at http://www.researchmoz.us/medical-equipments-market-reports-109.html
What you will gain:
An in-depth understanding of the global personalized medicine market and its environment
Current market facts, figures and product lines of key players in the industry
Emerging trends in key markets such as the US, UK, Germany and France
Knowledge of how the personalized medicine market will integrate into the global healthcare market
Technical insights into new generation sequencing technologies and ultra-high throughput sequencing
Updates on bioinformatics, high throughput systems, genetic analysis kits, companion diagnostics and future technologies
FDA approved pharmacogenetic tests and recognized biomarkers
Information on key government and regulatory policies
Strategies on how to adapt and restructure current business models to this industry
This report tackles key concerns to the personalized medicine market such as:
Lack of regulatory policy and legislation in the US and Europe
Reimbursement schemes and payers concerns
Transition of investigational diagnostic assays and therapeutics to clinical practice
Direct to consumer (DTC) test kits and implications for the public
Who should read this report?
Pharmaceutical, biotechnology and diagnostic companies with an interest in personalized medicine
Industry professionals and business strategists will discover key information to propel their policies
Investors will gain inside information to dominant players in the industry and future forecasts
Scientists will get a business perspective and industry insight into how scientific breakthroughs influence the market environment
This report will tell you if the companies mentioned are:
Strong, competitive players
Pooling their resources for specific growth and therapeutic areas
Investing strategically in R&D
Have a history of strategic M&A activity
Related Reports -
Infusion Pumps Market (Large Volume, Disposable, Syringe, Ambulatory and Implantable) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Infusion pumps are used to deliver therapeutic drugs and fluids such as plasma, dextrose and saline solutions, into a patient’s body at a precisely controlled rate. These devices are efficiently used for infusion through several routes of administration such as intravenous, epidural, arterial, subcutaneous, peritoneal, enteral and intrathecal. The global infusion pumps market has witnessed significant growth in the past due to factors such as worldwide increase in number of patients with chronic pain, diabetes and cancer. This report provides an in-depth, comprehensive analysis of the global infusion pumps market from the three perspectives namely types of products, different applications and the major geographies.
View Full Report With Complete TOC at http://www.researchmoz.us/infusion-pumps-market-large-volume-disposable-syringe-ambulatory-and-implantable-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019-report.html.
China Portable Medical Equipment Industry Report 2013 - 2016
With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with market size growing at a CAGR of 28.3% in 2008-2013 to approximately RMB44.21 billion in 2013.
Allowing for the low penetration of portable medical devices (for example, market penetration of household glucometer is under 10% as opposed to the level of 90% in Europe, the United States and other developed countries), increasingly aging population, etc., China’s portable medical device market size is expected to remain above 25% growth rate in 2013-2016.
View Full Report With Complete TOC at http://www.researchmoz.us/china-portable-medical-equipment-industry-report-2013-2016-report.html.
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
Website: http://www.researchmoz.us/
Email: sales(at)researchmoz(dot)us
Michell Thoras, ResearchMoz, http://www.researchmoz.us/, +1-518-618-1030, [email protected]
Share this article